— Know what they know.
Not Investment Advice

PKI NYSE

PerkinElmer, Inc.
1W: +5.3% 1M: -10.8% 3M: -6.6% 1Y: -17.8% 3Y: +30.8% 5Y: +59.5%
$115.24
Last traded 2023-05-23 — delisted
NYSE · Healthcare · Medical - Diagnostics & Research · $14.5B mcap · 116M float · 0.699% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$2.9B +3.7% ▲
5Y CAGR: -0.2%
Gross Profit
$1.6B -8.7% ▼
5Y CAGR: +2.3%
Operating Income
$357M +2.9% ▲
5Y CAGR: -0.3%
Net Income
$241M -10.8% ▼
5Y CAGR: +1.2%
EPS (Diluted)
$2.07 -6.8% ▼
5Y CAGR: +0.3%
EBITDA
$766M +120.9% ▲
5Y CAGR: +8.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2024FY2025
Revenue$3.8B$5.1B$3.3B$2.8B$2.9B
YoY Growth+31.2%+34.0%-34.6%+0.0%+3.7%
Cost of Revenue$1.7B$2.2B$1.3B$1.0B$1.3B
Gross Profit$2.1B$2.9B$2.0B$1.7B$1.6B
Gross Margin55.8%56.3%60.1%62.2%54.8%
R&D Expenses$205M$275M$222M$197M$216M
SG&A Expenses$918M$1.2B$1.0B$994M$992M
Operating Expenses$1.1B$1.5B$1.2B$1.2B$1.2B
Operating Income$979M$1.3B$743M$347M$357M
Operating Margin25.9%26.3%22.4%12.6%12.5%
Interest Expense$50M$102M$104M$31M$92M
Income Before Tax$906M$1.3B$708M$316M$268M
Tax Expense$178M$348M$129M$33M$28M
Net Income$728M$932M$579M$270M$241M
Net Margin19.2%18.4%17.5%9.8%8.4%
EPS (Diluted)$6.49$8.08$4.58$2.22$2.07
EBITDA$1.2B$1.7B$1.2B$347M$766M
Shares Outstanding112M117M126M122M117M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms